CDKN1A and cancer: Moreover, lincRNA-p21 has also been found to play diverse roles in genotoxic, hypoxic and ER stress responses during cancer progression [29,54,134], indicating that when combining with specific stress-responsive factors, lincRNA-p21 has the potential to serve as a biomarker for precisely predicting disease prognosis or therapy response.